CLK3 and cholangiocarcinoma: CDC-like kinase 3 (CLK3) is a dual-specificity kinase that functions on substrates containing serine/threonine and tyrosine and is significantly upregulated in cholangiocarcinoma (CCA) and affecting the prognosis of patients through inhibiting purine metabolism [28].